Cracking the context-specific PI3K signaling code

Different cellular and environmental contexts produce distinct biological outcomes for PI3K signaling. Specificity in signal transduction is determined by the ability of cells to “encode” and subsequently “decode” different environmental signals. Akin to computer software, this “signaling code” governs context-dependent execution of cellular programs through modulation of signaling dynamics and can be corrupted by disease-causing mutations. Class IA phosphoinositide 3-kinase (PI3K) signaling is critical for normal growth and development and is dysregulated in human disorders such as benign overgrowth syndromes, cancer, primary immune deficiency, and metabolic syndrome. Despite decades of PI3K research, understanding of context-dependent regulation of the PI3K pathway and of the underlying signaling code remains rudimentary. Here, we review current knowledge on context-specific PI3K signaling and how technological advances now make it possible to move from a qualitative to quantitative understanding of this pathway. Insight into how cellular PI3K signaling is encoded or decoded may open new avenues for rational pharmacological targeting of PI3K-associated diseases. The principles of PI3K context-dependent signal encoding and decoding described here are likely applicable to most, if not all, major cell signaling pathways.

[1]  Ken Chen,et al.  Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations. , 2015, Cancer research.

[2]  J. Saez-Rodriguez,et al.  A rapidly reversible chemical dimerizer system to study lipid signaling in living cells. , 2014, Angewandte Chemie.

[3]  R. Weinberg,et al.  Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.

[4]  M. Tatsuta,et al.  Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia. , 2005, Biochemical and biophysical research communications.

[5]  Hernan G. Garcia,et al.  Enhancer priming enables fast and sustained transcriptional responses to Notch signaling , 2018, bioRxiv.

[6]  Laureline Berteloot,et al.  Targeted therapy in patients with PIK3CA-related overgrowth syndrome , 2018, Nature.

[7]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[8]  W. Hahn,et al.  Transformation of Human and Murine Fibroblasts without Viral Oncoproteins , 2005, Molecular and Cellular Biology.

[9]  James Briscoe,et al.  Gene Regulatory Logic for Reading the Sonic Hedgehog Signaling Gradient in the Vertebrate Neural Tube , 2012, Cell.

[10]  K. Yoshida,et al.  Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. , 2001, The Biochemical journal.

[11]  Nicolai J. Birkbak,et al.  Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling , 2017, Nature Communications.

[12]  Chad J. Miller,et al.  Kinome-wide Decoding of Network-Attacking Mutations Rewiring Cancer Signaling , 2015, Cell.

[13]  Jan C. Refsgaard,et al.  Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites , 2019, Cell.

[14]  Carlos Cordon-Cardo,et al.  Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.

[15]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[16]  H. Ressom,et al.  Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA , 2006, Molecular and Cellular Biology.

[17]  Lovelace J. Luquette,et al.  A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. , 2017, Cancer cell.

[18]  R. Milo,et al.  Variability and memory of protein levels in human cells , 2006, Nature.

[19]  Asim Khwaja,et al.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.

[20]  High-dose oncogenic PIK3CA drives constitutive cellular stemness through self-sustained TGFbeta pathway activation , 2019 .

[21]  D. Nimbalkar,et al.  Cytokine activation of phosphoinositide 3-kinase sensitizes hematopoietic cells to cisplatin-induced death. , 2003, Cancer research.

[22]  T. Graeber,et al.  PTEN opposes negative selection and enables oncogenic transformation of pre-B cells , 2016, Nature Medicine.

[23]  J. Baselga,et al.  Pharmacology in the Era of Targeted Therapies: The Case of PI3K Inhibitors , 2016, Clinical Cancer Research.

[24]  Ralitsa R. Madsen,et al.  Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability , 2019, Biomolecules.

[25]  C. Holding,et al.  Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.

[26]  P. Hawkins,et al.  PI3K signalling: the path to discovery and understanding , 2012, Nature Reviews Molecular Cell Biology.

[27]  K. Okkenhaug,et al.  The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function , 2019, The Journal of Immunology.

[28]  A. Bilancio,et al.  Signalling by PI3K isoforms: insights from gene-targeted mice. , 2005, Trends in biochemical sciences.

[29]  Lewis C. Cantley,et al.  Cell-to-Cell Variability in PI3K Protein Level Regulates PI3K-AKT Pathway Activity in Cell Populations , 2011, Current Biology.

[30]  Ali Najafi,et al.  Seminars in Cancer Biology , 2014 .

[31]  D J Glass,et al.  Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. , 1999, Science.

[32]  B. Vanhaesebroeck,et al.  Lessons for cancer drug treatment from tackling a non-cancerous overgrowth syndrome , 2018, Nature.

[33]  Pauline Traynard,et al.  Logic Modeling in Quantitative Systems Pharmacology , 2017, CPT: pharmacometrics & systems pharmacology.

[34]  A. Sherman,et al.  A mathematical model of metabolic insulin signaling pathways. , 2002, American journal of physiology. Endocrinology and metabolism.

[35]  Adam Naguib Following the trail of lipids: Signals initiated by PI3K function at multiple cellular membranes , 2016, Science Signaling.

[36]  Peter Butler,et al.  Pulsatile insulin secretion: detection, regulation, and role in diabetes. , 2002, Diabetes.

[37]  M. Elowitz,et al.  Functional Roles of Pulsing in Genetic Circuits , 2013, Science.

[38]  Ralitsa R. Madsen,et al.  High-dose oncogenic PIK3CA drives constitutive cellular stemness through self-sustained TGFβ pathway activation , 2019, bioRxiv.

[39]  Lewis C. Cantley,et al.  The PI3K Pathway in Human Disease , 2017, Cell.

[40]  Johan Karlsson,et al.  Heterogeneous kinetics of AKT signaling in individual cells are accounted for by variable protein concentration , 2012, Front. Physio..

[41]  Shinya Kuroda,et al.  Temporal coding of insulin action through multiplexing of the AKT pathway. , 2012, Molecular cell.

[42]  M. Boerries,et al.  Understanding the mTOR signaling pathway via mathematical modeling , 2017, Wiley interdisciplinary reviews. Systems biology and medicine.

[43]  L. Hansen,et al.  Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis , 2008, Journal of Cell Science.

[44]  Julio Saez-Rodriguez,et al.  Modeling Signaling Networks to Advance New Cancer Therapies. , 2015, Annual review of biomedical engineering.

[45]  Lizhong Liu,et al.  Rapid changes in morphogen concentration control self-organized patterning in human embryonic stem cells , 2019, eLife.

[46]  Mina Bissell,et al.  Reproducibility: The risks of the replication drive , 2013, Nature.

[47]  G. Shulman,et al.  Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.

[48]  Liying Wang,et al.  Phosphatidylinositol 3-Kinase/Akt Positively Regulates Fas (CD95)-Mediated Apoptosis in Epidermal Cl41 Cells1 , 2006, The Journal of Immunology.

[49]  Mark Merchant,et al.  Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. , 2012, Cancer research.

[50]  C. Betsholtz,et al.  Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis. , 2016, Cell stem cell.

[51]  C. Kiel,et al.  From oncogenic mutation to dynamic code , 2018, Science.

[52]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[53]  P. Bastiaens,et al.  Contact inhibitory Eph signaling suppresses EGF-promoted cell migration by decoupling EGFR activity from vesicular recycling , 2018, Science Signaling.

[54]  A. Coster,et al.  The Akt switch model: Is location sufficient? , 2016, Journal of theoretical biology.

[55]  Rugang Zhang,et al.  Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. , 2011, Molecular cell.

[56]  Dalya R. Soond,et al.  Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer , 2016, Nature.

[57]  Nir Friedman,et al.  Dynamic response diversity of NFAT isoforms in individual living cells. , 2013, Molecular cell.

[58]  Andrius Kazlauskas,et al.  PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1 , 1999, Current Biology.

[59]  M. Okabe,et al.  Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells , 2006, Oncogene.

[60]  Tom H. Cheung,et al.  p110α of PI3K is necessary and sufficient for quiescence exit in adult muscle satellite cells , 2018, The EMBO journal.

[61]  N. Hay,et al.  Akt Activation Emulates Chk1 Inhibition and Bcl2 Overexpression and Abrogates G2 Cell Cycle Checkpoint by Inhibiting BRCA1 Foci* , 2010, The Journal of Biological Chemistry.

[62]  Benjamin M. Gyori,et al.  Encoding Growth Factor Identity in the Temporal Dynamics of FOXO3 under the Combinatorial Control of ERK and AKT Kinases. , 2018, Cell systems.

[63]  M. McMahon,et al.  Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[64]  L. Rassenti,et al.  Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. , 2016, Blood.

[65]  Timothy K Lee,et al.  Single-cell NF-κB dynamics reveal digital activation and analogue information processing , 2010, Nature.

[66]  Xi C. He,et al.  PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.

[67]  Dalya R. Soond,et al.  Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer , 2014, Nature.

[68]  J. Engelman,et al.  Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice , 2005, Molecular and Cellular Biology.

[69]  Shinya Kuroda,et al.  An optogenetic system for interrogating the temporal dynamics of Akt , 2015, Scientific Reports.

[70]  N. Ahn,et al.  Distinct Cell Cycle Timing Requirements for Extracellular Signal-Regulated Kinase and Phosphoinositide 3-Kinase Signaling Pathways in Somatic Cell Mitosis , 2002, Molecular and Cellular Biology.

[71]  A. Saltiel,et al.  Activation of Mitogen-activated Protein Kinase and Phosphatidylinositol 3′-Kinase Is Not Sufficient for the Hormonal Stimulation of Glucose Uptake, Lipogenesis, or Glycogen Synthesis in 3T3-L1 Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[72]  B. Kholodenko,et al.  The dynamic control of signal transduction networks in cancer cells , 2015, Nature Reviews Cancer.

[73]  K. Okkenhaug Rules of engagement: distinct functions for the four class I PI3K catalytic isoforms in immunity , 2013, Annals of the New York Academy of Sciences.

[74]  S. Morrison,et al.  Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.

[75]  Tobias Meyer,et al.  Supplemental Experimental Procedures A Two-Dimensional ERK-AKT Signaling Code for an NGF-Triggered Cell-Fate Decision , 2011 .

[76]  F. Meric-Bernstam,et al.  Targeting the PI3K pathway in cancer: are we making headway? , 2018, Nature Reviews Clinical Oncology.

[77]  K. Okkenhaug,et al.  Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy. , 2016, Cancer discovery.

[78]  M. Gorospe,et al.  Caveolin-Induced Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Increases Arsenite Cytotoxicity , 2003, Molecular and Cellular Biology.

[79]  May Yin Lee,et al.  Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.

[80]  Katharina F. Sonnen,et al.  Dynamic signal encoding--from cells to organisms. , 2014, Seminars in cell & developmental biology.

[81]  A. Brivanlou,et al.  Dynamics of TGF-β signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4 , 2012, Proceedings of the National Academy of Sciences.

[82]  P. Tsichlis,et al.  Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[83]  S. Baylin,et al.  Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. , 2014, Molecular cell.

[84]  P. Cohen,et al.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. , 1992, The Biochemical journal.

[85]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[86]  Aleksander S. Popel,et al.  Endothelial cells decode VEGF-mediated Ca2+ signaling patterns to produce distinct functional responses , 2016, Science Signaling.

[87]  E. Lo,et al.  Akt and mTOR mediate programmed necrosis in neurons , 2014, Cell Death and Disease.

[88]  Hiroyuki Kubota,et al.  Decoupling of Receptor and Downstream Signals in the Akt Pathway by Its Low-Pass Filter Characteristics , 2010, Science Signaling.

[89]  Moritoshi Sato,et al.  Engineered pairs of distinct photoswitches for optogenetic control of cellular proteins , 2015, Nature Communications.

[90]  Orion D. Weiner,et al.  Illuminating cell signalling with optogenetic tools , 2014, Nature Reviews Molecular Cell Biology.

[91]  N. Hay,et al.  Akt, a Target of Phosphatidylinositol 3-Kinase, Inhibits Apoptosis in a Differentiating Neuronal Cell Line , 1998, Molecular and Cellular Biology.

[92]  Bertram Klinger,et al.  Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type-Specific Dynamic Logic Models. , 2017, Cancer research.

[93]  M. Rubin,et al.  Suppression of insulin feedback enhances the efficacy of PI3K inhibitors , 2018, Nature.

[94]  D. Bray Protein molecules as computational elements in living cells , 1995, Nature.

[95]  C. Martínez-A,et al.  Forkhead transcription factors contribute to execution of the mitotic programme in mammals , 2001, Nature.

[96]  Peter K. Sorger,et al.  Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method , 2015, Nature Communications.

[97]  N. Hay,et al.  Quantitative Lipid Imaging Reveals a New Signaling Function of Phosphatidylinositol-3,4-Bisphophate: Isoform- and Site-Specific Activation of Akt. , 2018, Molecular cell.

[98]  Jared E. Toettcher,et al.  Signaling Dynamics Control Cell Fate in the Early Drosophila Embryo. , 2019, Developmental cell.

[99]  Jacob J. Hughey,et al.  NF-κB signaling dynamics is controlled by a dose-sensing autoregulatory loop , 2019, Science Signaling.

[100]  James Briscoe,et al.  Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism , 2007, Nature.

[101]  Christina S. Leslie,et al.  Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs , 2017, Nature Communications.

[102]  Amit Kumar,et al.  Phosphoinositide 3-Kinases p110α and p110β Regulate Cell Cycle Entry, Exhibiting Distinct Activation Kinetics in G1 Phase , 2008, Molecular and Cellular Biology.

[103]  A. Klippel,et al.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.

[104]  Sean M. Gross,et al.  Unraveling Growth Factor Signaling and Cell Cycle Progression in Individual Fibroblasts* , 2016, The Journal of Biological Chemistry.

[105]  John G. Albeck,et al.  Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals. , 2013, Molecular cell.

[106]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[107]  Alexander Hoffmann,et al.  The Dynamics of Signaling as a Pharmacological Target , 2013, Cell.

[108]  Aryeh Warmflash,et al.  Encoding of temporal signals by the TGF-β pathway and implications for embryonic patterning. , 2014, Developmental cell.

[109]  T. Bivona Dampening oncogenic RAS signaling , 2019, Science.

[110]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[111]  A. Warmflash,et al.  Synergy with TGFβ ligands switches WNT pathway dynamics from transient to sustained during human pluripotent cell differentiation , 2019, Proceedings of the National Academy of Sciences.

[112]  Annie Z. Tremp Malaria: Plasmodium develops in lymph nodes , 2006, Nature Reviews Microbiology.

[113]  M. Elowitz,et al.  Dynamic Ligand Discrimination in the Notch Signaling Pathway , 2018, Cell.

[114]  I. Komuro,et al.  Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21‐dependent pathway , 2004, The EMBO journal.

[115]  O. Delpuech,et al.  Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA-Dependent Breast Cancers , 2016, Molecular Cancer Therapeutics.

[116]  N. Hay,et al.  Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.

[117]  N. Hay,et al.  The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. , 1997, Genes & development.

[118]  David E. James,et al.  Amplification and Demultiplexing in Insulin-regulated Akt Protein Kinase Pathway in Adipocytes* , 2011, The Journal of Biological Chemistry.

[119]  S. Rafii,et al.  Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells , 2010, Nature Cell Biology.

[120]  L. Rubin,et al.  Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons , 1997, The Journal of cell biology.

[121]  E. Tran,et al.  Deletion of the Imprinted Gene Grb10 Promotes Hematopoietic Stem Cell Self-Renewal and Regeneration. , 2016, Cell reports.

[122]  Zhihui Wang,et al.  Dynamic Targeting in Cancer Treatment , 2019, Front. Physiol..

[123]  Jackelyn A. Alva,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Phosphatase and Tensin Homolog Regulates the Pluripotent State and Lineage Fate Choice in Human Embryonic Stem Cells , 2011 .

[124]  Jared E. Toettcher,et al.  Light-based feedback for controlling intracellular signaling dynamics , 2011, Nature Methods.

[125]  B. Kholodenko Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[126]  T. Meyer,et al.  A PI3-Kinase Signaling Code for Insulin-Triggered Insertion of Glucose Transporters into the Plasma Membrane , 2002, Current Biology.

[127]  C. Yau,et al.  Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma , 2019, Nature Communications.

[128]  Ralitsa R. Madsen,et al.  Cancer-Associated PIK3CA Mutations in Overgrowth Disorders , 2018, Trends in molecular medicine.

[129]  ChangHwan Lee,et al.  Dynamics of Notch-Dependent Transcriptional Bursting in its Native Context , 2018, bioRxiv.

[130]  B. Sloth,et al.  Effective ‘ Activated PI 3 K δ Syndrome ’-targeted therapy with the PI 3 K δ inhibitor leniolisib Running head : Effective therapy of APDS by PI 3 K δ inhibitor leniolisib , 2017 .

[131]  D. Stokoe,et al.  A Role for PI 3-Kinase and PKB Activity in the G2/M Phase of the Cell Cycle , 2002, Current Biology.

[132]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[133]  I. Majewski On fitness: how do mutations shape the biology of cancer? , 2019, Biochemical Society transactions.

[134]  T. Fujimiya,et al.  Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2 , 2003, Oncogene.

[135]  R. Pearson,et al.  AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy , 2011, Oncogene.

[136]  J. Gribben,et al.  Empirical inference of circuitry and plasticity in a kinase signaling network , 2015, Proceedings of the National Academy of Sciences.

[137]  Shinya Kuroda,et al.  In Vivo Decoding Mechanisms of the Temporal Patterns of Blood Insulin by the Insulin-AKT Pathway in the Liver. , 2018, Cell systems.

[138]  A. Eastman,et al.  Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer , 2016, Clinical Cancer Research.

[139]  B. Vanhaesebroeck,et al.  PI3K isoforms in cell signalling and vesicle trafficking , 2019, Nature Reviews Molecular Cell Biology.

[140]  Lucas Pelkmans,et al.  Multiplexed protein maps link subcellular organization to cellular states , 2018, Science.

[141]  Gerald R. V. Hammond,et al.  Genetically encoded lipid biosensors , 2018, Molecular biology of the cell.

[142]  S. Beronja,et al.  Oncogenic activation of PI3K induces progenitor cell differentiation to suppress epidermal growth , 2018, Nature Cell Biology.

[143]  W. Zong,et al.  Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition* , 2009, The Journal of Biological Chemistry.

[144]  Michael B. Stadler,et al.  PIK3CAH1047R induces multipotency and multi-lineage mammary tumours , 2015, Nature.

[145]  S. Chandarlapaty,et al.  Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling. , 2014, Cancer discovery.

[146]  L. Cantley,et al.  Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate , 1988, Nature.

[147]  Peter K. Sorger,et al.  Sporadic ERK pulses drive non-genetic resistance in drug-adapted BRAFV600E melanoma cells , 2019, bioRxiv.

[148]  A. Klippel,et al.  Activation of Phosphatidylinositol 3-Kinase Is Sufficient for Cell Cycle Entry and Promotes Cellular Changes Characteristic of Oncogenic Transformation , 1998, Molecular and Cellular Biology.

[149]  G. Lahav,et al.  Encoding and Decoding Cellular Information through Signaling Dynamics , 2013, Cell.

[150]  Jared E. Toettcher,et al.  Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway , 2018, Science.

[151]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[152]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[153]  M. Inoue,et al.  Activation of insulin-like growth factor signaling induces apoptotic cell death under prolonged hypoxia by enhancing endoplasmic reticulum stress response. , 2007, Cancer research.

[154]  D. Voskas,et al.  Activation of PDK-1 maintains mouse embryonic stem cell self-renewal in a PKB-dependent manner , 2013, Oncogene.

[155]  Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner , 2018 .

[156]  Sean M. Gross,et al.  Mapping growth-factor-modulated Akt signaling dynamics , 2016, Development.

[157]  Takeshi Norimatsu,et al.  Encoding and Decoding , 2016 .

[158]  C. Heisenberg,et al.  Optogenetic Control of Nodal Signaling Reveals a Temporal Pattern of Nodal Signaling Regulating Cell Fate Specification during Gastrulation. , 2016, Cell reports.

[159]  Benjamin Lin,et al.  Toward total synthesis of cell function: Reconstituting cell dynamics with synthetic biology , 2016, Science Signaling.

[160]  I. Greenwald,et al.  A Real-Time Biosensor for ERK Activity Reveals Signaling Dynamics during C. elegans Cell Fate Specification. , 2017, Developmental cell.

[161]  Hiroyuki Kubota,et al.  A Quantitative Image Cytometry Technique for Time Series or Population Analyses of Signaling Networks , 2010, PloS one.

[162]  Phillip G. Montgomery,et al.  Defining a Cancer Dependency Map , 2017, Cell.